Masaru Ken Shiratori is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of mammalian cell technology. With a total of 3 patents to his name, Shiratori's work has advanced the understanding and application of cellular processes.

Latest Patents

Shiratori's latest patents include innovative methods for modulating lactogenic activity in mammalian cells. This patent focuses on producing products of interest, such as recombinant proteins, by improving mammalian cells, specifically Chinese Hamster Ovary (CHO) cells. The methods described also involve modulating pyruvate kinase muscle (PKM) expression to reduce or eliminate lactogenic activity in these cells. Another significant patent addresses methods for viral inactivation and other adventitious agents, utilizing high temperature short time (HTST) treatment to minimize the generation of precipitate during the process.

Career Highlights

Masaru Ken Shiratori is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to apply his expertise in mammalian cell technology to real-world applications, contributing to the advancement of therapeutic solutions.

Collaborations

Shiratori has collaborated with esteemed colleagues, including Robert David Kiss and Hardayal Prashad. These collaborations have fostered a productive environment for innovation and have led to the development of groundbreaking technologies in the field.

Conclusion

Masaru Ken Shiratori's contributions to biotechnology, particularly in mammalian cell technology, have positioned him as a key inventor in the industry. His patents reflect a commitment to advancing scientific knowledge and improving biotechnological applications.

This text is generated by artificial intelligence and may not be accurate.